RxElite, Inc.
RXEI · OTC
12/31/2007 | 9/30/2006 | 9/30/2005 | 9/30/2004 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $10 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | -$9 | -$0 | $0 | $0 |
| Revenue | $3 | $1 | $1 | $1 |
| % Growth | 139% | 21.7% | 15.7% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 5.1% | 63.1% | 53.5% | 100% |
| EBITDA | -$16 | $0 | -$0 | $1 |
| % Margin | -585.6% | 13.4% | -3% | 100% |
| Net Income | -$17 | $0 | -$0 | -$0 |
| % Margin | -610.5% | 8% | -3.7% | -4.1% |
| EPS Diluted | -0.27 | 0.009 | -0.004 | 0 |
| % Growth | -3,100% | 350% | – | – |
| Operating Cash Flow | -$13 | $0 | $0 | – |
| Capital Expenditures | -$2 | -$0 | -$0 | – |
| Free Cash Flow | -$15 | $0 | -$0 | – |